Search results
HighPoint Advisor Group LLC Buys Shares of 17,818 Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 6 hours agoHighPoint Advisor Group LLC bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, Holdings ...
Gilead Sciences Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 5 days agoGilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-06-27, with the ex-dividend date ...
Shareholders in Gilead Sciences (NASDAQ:GILD) are in the red if they invested a year ago
Simply Wall St. via Yahoo Finance· 1 hour agoWhen you buy individual stocks, you can make higher profits, but you also face the risk of...
Gilead Sciences, Inc. (NASDAQ:GILD) Short Interest Up 17.2% in May
ETF DAILY NEWS· 1 day agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) was the target of a significant increase in short interest during the month of ...
2,387 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Spartan Planning & Wealth...
ETF DAILY NEWS· 2 days agoSpartan Planning & Wealth Management purchased a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the fourth quarter ...
Slagle Financial LLC Has $4.14 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 2 days agoSlagle Financial LLC boosted its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 99.0% during the 4th quarter, according ...
Gilead Sciences Target of Unusually High Options Trading (NASDAQ:GILD)
ETF DAILY NEWS· 3 days agoGilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) saw unusually large options trading on Friday. Gilead Sciences has a 52-week low ...
EU regulator mandates label updates on CAR-T cancer therapies
Reuters· 5 days agoThe European health regulator said on Friday product information for a class of cancer therapies...
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks· 2 days agoFree Report) , a passively managed exchange traded fund launched on 12/20/2011. An increasingly popular option among retail and institutional investors, passively managed ETFs offer low costs ...
VC's new $900 million fund looks to push tech-biotech innovation - San Francisco Business Times
The Business Journals· 7 days agoForesite Capital, one of the more-active venture capital firms at the intersection of biotech and...
